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Abstract
The aim of the present study was to assess ultrasonography
(US) for the detection of inflammatory and destructive changes
in finger and toe joints, tendons, and entheses in patients with
psoriasis-associated arthritis (PsA) by comparison with
magnetic resonance imaging (MRI), projection radiography (x-
ray), and clinical findings. Fifteen patients with PsA, 5 with
rheumatoid arthritis (RA), and 5 healthy control persons were
examined by means of US, contrast-enhanced MRI, x-ray, and
clinical assessment. Each joint of the 2nd–5th finger
(metacarpophalangeal joints, proximal interphalangeal [PIP]
joints, and distal interphalangeal [DIP] joints) and 1st–5th
metatarsophalangeal joints of both hands and feet were
assessed with US for the presence of synovitis, bone erosions,
bone proliferations, and capsular/extracapsular power Doppler
signal (only in the PIP joints). The 2nd–5th flexor and extensor
tendons of the fingers were assessed for the presence of
insertional changes and tenosynovitis. One hand was assessed
by means of MRI for the aforementioned changes. X-rays of both
hands and feet were assessed for bone erosions and
proliferations. US was repeated in 8 persons by another
ultrasonographer. US and MRI were more sensitive to
inflammatory and destructive changes than x-ray and clinical
examination, and US showed a good interobserver agreement
for bone changes (median 96% absolute agreement) and lower
interobserver agreement for inflammatory changes (median
92% absolute agreement). A high absolute agreement (85% to
100%) for all destructive changes and a more moderate
absolute agreement (73% to 100%) for the inflammatory
pathologies were found between US and MRI. US detected a
higher frequency of DIP joint changes in the PsA patients
compared with RA patients. In particular, bone changes were
found exclusively in PsA DIP joints. Furthermore, bone
proliferations were more common and tenosynovitis was less
frequent in PsA than RA. For other pathologies, no disease-
specific pattern was observed. US and MRI have major potential
for improved examination of joints, tendons, and entheses in
fingers and toes of patients with PsA.
Introduction
Arthritis in small joints is common in psoriasis-associated
arthritis (PsA), and the clinical distinction from rheumatoid
arthritis (RA) can be difficult [1]. Improved therapy options and
knowledge of the importance of early initiation of aggressive
treatments to optimize long-term outcome in patients [2-5]
have led to an increasing focus on developing new sensitive
diagnostic and monitoring tools. Imaging modalities such as
Acq = number of acquisitions; CT = computed tomography; CTRL = healthy control person; DIP = distal interphalangeal; EULAR = European League 
Against Rheumatism; FOV = field of view; MCP = metacarpophalangeal; MRI = magnetic resonance imaging; MTP = metatarsophalangeal; OA = 
osteoarthritis; PD = power Doppler; PIP = proximal interphalangeal; PsA = psoriasis-associated arthritis; RA = rheumatoid arthritis; ST = slice thick-
ness; TA = acquisition time; TE = echo time; TI = inversion time; TR = repetition time; US = ultrasonography; US1 = ultrasonographer 1 (Charlotte 
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ultrasonography (US) and magnetic resonance imaging (MRI)
appear promising. MRI can detect inflammation and bone
destruction in joints earlier than projection radiography (x-ray)
in PsA, RA, and spondyloarthritis can [6-8]. US is a tool
increasingly used by clinicians, including rheumatologists, but
the US data on small joints in PsA are very limited [8,9]; in
particular, the validation of the findings is minimal. The aim of
the present study was to assess US for the detection of inflam-
matory and destructive changes in finger and toe joints, ten-
dons, and entheses in patients with PsA by comparison with
MRI, x-ray, and clinical findings.
Materials and methods
Patients
Fifteen patients with PsA, 5 with RA, and 5 healthy control per-
sons (CTRLs) were examined with US, contrast-enhanced
MRI, x-ray, and clinical assessment. The PsA and RA patients
were required to have at least one clinically affected finger joint
or dactylitis to enter the study. The PsA group included 11
women and 4 men with a median age of 57 years (range 39 to
79) and a median disease duration of 3 years (range 0 to 24).
They had a median of 5 tender joints (range 1 to 24) and 2
swollen joints (range 1 to 10). The RA group comprised 5
women with a median age of 48 years (range 32 to 60) and a
median disease duration of 7 years (range 0 to 15). Their
median tender and swollen joint counts were 8 (range 3 to 9)
and 6 (range 2 to 11), respectively. All 5 CTRLs (4 women and
1 man with a median age of 63 years; range 35 to 71) had no
prior history of rheumatological disease and no clinically
affected joints at inclusion. The study participants signed con-
sent forms after receiving oral and written information. The
study was approved by the local Danish ethics committee.
Ultrasonography
US was performed with a GE LOGIQ 9 unit (General Electric
Medical Systems, now known as GE Healthcare, Little Chal-
font, Buckinghamshire, UK) using a high-frequency 9- to 14-
MHz linear array transducer. All persons were examined by the
same trained ultrasonographer (CW = US1) and examination
was repeated in 8 persons (6 PsA, 1 RA, and 1 CTRL) by
another trained ultrasonographer (MS = US2), and both US1
and US2 have a rheumatological background (Figure 1). US2
was blinded to diagnosis and clinical data, and both were
blinded to other imaging findings, including the sonographic
findings of the other ultrasonographer. Bilateral 2nd–5th met-
acarpophalangeal (MCP), proximal interphalangeal (PIP), and
distal interphalangeal (DIP) joints and 1st–5th metatar-
sophalangeal (MTP) joints were assessed with US for inflam-
matory changes: synovitis (synovial hypertrophy and/or
effusion and/or power Doppler [PD] signal) and capsular/ext-
racapsular PD signal (only in PIP joints) (Figure 2). Further-
more, the tendons of the fingers (2nd–5th flexor and extensor
tendons) were assessed for insertional changes (edema and/
or calcification and/or periosteal changes and/or PD signal)
and tenosynovitis. Finally, all joints were assessed for bone
changes: bone erosions and bone proliferations. The pres-
ence or absence of each parameter was noted. The palmar
and dorsal aspects of each joint were examined in a longitudi-
nal plane. A transverse view was added in case of doubt con-
cerning the type of the detected finding or for confirmation of
an erosion. Additional views were radial view of the 2nd MCP
joint, ulnar view of the 5th MCP joint, radial and ulnar views of
all PIP joints, medial view of the 1st MTP joint, and lateral view
of the 5th MTP joint. All views were obtained with the hands
and feet in a neutral position. Mild synovitis in joints (score 1
according to the scoring system proposed by Szkudlarek and
colleagues [10] for MCP and MTP joints) and a small amount
of fluid in the tendon sheath below the flexor tendons at the
palmar side of the PIP joints were considered a normal finding.
A small amount of fluid around the fat pad on the palmar side
of the PIP joint and a synovial membrane thickness below 12
mm (measured at the site of maximal thickness) of the DIP
joints were also considered normal (based on unpublished
data from CTRLs by Wiell and colleagues). The following US
definitions were employed: bone erosion = bone cortex dis-
continuation in the area adjacent to the joint, visualized in two
planes; bone proliferation = bone cortex proliferation in the
area adjacent to the joint; synovitis = anechoic or hypoechoic
intracapsular area, different from cartilage with or without PD
signal; tenosynovitis = hypoechoic rim around the flexor ten-
don with or without PD signal; capsular/extracapsular
changes = PD signal (intracapsular and/or extracapsular at the
insertion of capsule or ligament) at the radial or ulnar sides of
the PIP joints, different from nutritious vessels; and insertional
changes = intratendinous hypoechoic enlargement and/or
intratendinous hyperechoic bands with or without acoustic
shadow and/or periosteal irregularities and/or intratendinous
PD signal at the entheses.
Ultrasonography parameters
The setting for grey-scale US was 14 MHz, and the pulse rep-
etition frequency for the PD signal was set at 500 Hz.
Magnetic resonance imaging
MRI was performed on a Philips Panorama 0.6 tesla unit
(Philips Medical Systems, Helsinki, Finland) using a three-
channel phased-array solenoid coil within 2 days of the US.
The more clinically affected hand (2nd–5th MCP, PIP, and DIP
joints) was assessed for the presence or absence of afore-
mentioned changes by a radiologist experienced in muscu-
loskeletal radiography (MH), who was blinded to clinical and
other imaging findings.
Magnetic resonance imaging parameters
The acquired images included a coronal T1-weighted three-
dimensional fast field echo (repetition time [TR] 20 ms, echo
time [TE] 8 ms, flip angle 25°, field of view [FOV] 120 mm,
matrix 240 × 240, slice thickness [ST] 0.8 mm, number of
acquisitions [Acq] 1, and acquisition time [TA] 4.31 minutes)
and axial fat saturated T1-weighted (TR 31 ms, TE 11 ms, flipAvailable online http://arthritis-research.com/content/9/6/R119
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angle 25°, FOV 150 mm, matrix 256 × 256, ST 4 mm, Acq 1,
and TA 4.57 minutes) sequences before and after intravenous
administration of the contrast agent Omniscan (0.1 mmol/kg;
Amersham Health AS, now part of GE Healthcare). Addition-
ally, sagittal (TR 4,000 ms, TE 17 ms, inversion time [TI] 80 ms,
flip angle 90°, FOV 160 mm, matrix 256 × 256, ST 3 mm, Acq
1, and TA 6.56 minutes) and axial (TR 3,000 ms, TE 17 ms, TI
80 ms, flip angle 90°, FOV 160 mm, matrix 256 × 256, ST 3
mm, Acq 1, and TA 7.01 minutes) short tau inversion recovery
(STIR) sequences were performed before contrast administra-
tion. Reconstructions were performed with a ST that was half
of the acquired ST.
Projection radiography
X-ray of hands and feet in a posterior-anterior projection was
performed within a month of the US. X-rays of both hands and
feet (2nd–5th MCP, PIP, DIP, and MTP joints) were assessed
for bone erosions and bone proliferations according to the
Figure 1
Ultrasonography (US) of distal interphalangeal (DIP) joints (a-c) and metatarsophalangeal (MTP) joints (d-f) Ultrasonography (US) of distal interphalangeal (DIP) joints (a-c) and metatarsophalangeal (MTP) joints (d-f). Images on the left were acquired inde-
pendently by ultrasonographer 1 (Charlotte Wiell) and middle images were acquired independently by ultrasonographer 2 (Marcin Szkudlarek) in the 
interobserver US substudy. (a,b) Bone proliferations (arrows) in the 2nd DIP joint on US in a palmar view in a patient with psoriasis-associated arthri-
tis (PsA). (d,e) Synovitis (arrows) in the 2nd MTP joint on US in a dorsal view in a patient with PsA. Images on the right show a 2nd DIP joint (c) and 
a 2nd MTP joint (f) without destructive or inflammatory changes on US. (f) Notice subcutaneous edema dorsal to the 2nd MTP joint. DP, distal pha-
lanx; IP, intermediate phalanx; M, metatarsal bone; PP, proximal phalanx.
Figure 2
(a) Capsular/extracapsular changes (arrows) on power Doppler ultrasonography on the radial side of the 2nd proximal interphalangeal joint in a  patient with psoriasis-associated arthritis (a) Capsular/extracapsular changes (arrows) on power Doppler ultrasonography on the radial side of the 2nd proximal interphalangeal joint in a 
patient with psoriasis-associated arthritis. (b,c) The corresponding coronal T1-weighted magnetic resonance images before (b) and after (c) con-
trast administration showing capsular/extracapsular post-contrast enhancement. IP, intermediate phalanx; PP, proximal phalanx.Arthritis Research & Therapy    Vol 9 No 6    Wiell et al.
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Ratingen scoring system [11] by an experienced musculoskel-
etal radiologist (AV) blinded to clinical and other imaging
findings.
Clinical examination
All 25 persons underwent clinical examination prior to US to
determine the presence or absence of swelling and/or tender-
ness of the finger and MTP joints (in all 34 joints per person).
One patient with PsA had had joint replacement in 4 MCP
joints and total anchylosis in one PIP joint. These joints were
not assessed.
Statistical analysis
Absolute agreements and unweighted kappa values between
US (US1), MRI, x-ray, and clinical examination were calculated.
Furthermore, the interobserver agreement between US1 and
US2 was determined. Kappa values below 0.20 were consid-
ered poor, 0.21 to 0.40 fair, 0.41 to 0.60 moderate, 0.61 to
0.80 good, and 0.81 to 1.00 very good [12]. MRI was used as
the standard reference method for the calculation of the sen-
sitivity and specificity of US, x-ray, and clinical examination
[12]. The statistical software used was SPSS version 12.0 for
Windows (SPSS Inc., Chicago, IL, USA).
Results
A total of 845 joints were examined by US, 300 by MRI, and
795 by x-ray.
Ultrasonography observations in PsA and RA patients 
and CTRLs
The observations by US in PsA and RA patients and CTRLs
are listed in Table 1. In particular, it was noted that the DIP
joints of patients with PsA had more pathological findings than
RA patients; especially, no bone changes (erosions and prolif-
erations) were present in the RA patients. Bone changes
found in the MTP joints were primarily at the medial side of the
1st MTP joint. In CTRLs, nine erosion-like changes were seen
by US (Figure 3). All were located at the radial and ulnar side
of the 2nd and 3rd PIP joints and the 5th MCP joints and at
the medial side of 1st MTP joints. In the finger joints, the size
of the bone cortex defect was below 12 mm; in the MTP joints,
the size was below 20 mm. Bone proliferations were found in
two CTRL DIP joints. Synovitis was common in both groups of
patients, although we found a tendency toward more synovitis
in the MCP and PIP joints in RA patients. A high frequency of
synovitis was registered in MTP joints, including in CTRLs. The
frequency of tenosynovitis was generally higher in RA than
PsA patients, whereas insertional changes and capsular/ext-
racapsular changes were found more frequently, but not exclu-
sively, in PsA.
Observations by ultrasonography, MRI, and x-ray in the 
MRI-examined hand
The observations by US, MRI, and x-ray in the MRI-examined
hand are listed in Table 2. Both US and MRI were more sensi-
tive in detecting bone changes than x-ray, except in DIP joints.
US and MRI found inflammatory changes with an equal fre-
quency, although US discovered slightly more than MRI in the
distal part of the finger. In particular, it was noted that US
found more erosions in the PIP joints than either MRI or x-ray.
The opposite was the case for DIP joint erosions. US and MRI
detected more bone proliferations in the MCP and PIP joints
and more erosions in the MCP joints than x-ray. US generally
detected pathological changes (except erosions) in the DIP
joints more frequently than MRI. None of the bone changes
(four erosion-like changes) found by US in CTRLs was con-
firmed by MRI. Synovitis was not registered by US in any CTRL
and was found in only one PIP joint by MRI. Synovitis was dis-
covered more frequently in the DIP joint by US, whereas no
apparent difference between US and MRI was found in the
other finger joints. Insertional changes were seen with a com-
parable frequency by US and MRI, although more changes at
the insertion of the flexor tendons were registered by US. Cap-
sular/extracapsular changes were predominantly visualized by
US.
Ultrasonography interobserver agreement
The results of the US interobserver substudy are listed in Table
3 (bone changes) and Table 4 (inflammatory changes). The
absolute agreements for both bone and inflammatory changes
were high (median 96%; range 50% to 100%), except for syn-
ovitis and tenosynovitis at the PIP joints in patients with RA
(50% and 63%). The kappa values were good to very good for
all bone changes (kappa 0.60 to 1.00), except for bone prolif-
erations in MTP joints (0.52) and erosions in PIP joints (0.52).
The strength of agreement for synovitis in MTP joints was
good to very good (kappa 0.78 to 1.00) but for other inflam-
matory findings the agreements were poor to fair (kappa -0.05
to 0.37). US1 registered pathological findings more frequently
than US2.
Agreement between ultrasonography, MRI, x-ray, and 
clinical examination
The agreements between US, MRI, and x-ray for bone
changes are listed in Table 3, and the agreements between
US, MRI, and clinical examination for inflammatory changes
are listed in Table 4. The absolute agreement between the
imaging modalities was generally high for bone changes
(median 95%; range 78% to 100%) and was lowest for ero-
sions in MTP joints. The absolute agreements between US
and MRI for inflammatory changes were slightly lower (median
91%; range 73% to 100%) and were lowest for synovitis and
tenosynovitis in the PIP joints. In contrast, the kappa values
were higher for inflammatory changes (median 0.51; range
0.04 to 1.00) than for bone changes (median 0.40; range -
0.08 to 0.66). X-ray findings that were not revealed by US
included erosions in 3 MCP joints (PsA), 13 PIP joints (10 PsA
and 3 RA), and 8 DIP joints (PsA) and proliferations in 3 DIP
joints (PsA). In the 2nd–4th MTP joints, x-ray detected 6 ero-
sions that were not found by US (4 PsA and 2 RA). Most of theAvailable online http://arthritis-research.com/content/9/6/R119
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erosions visible by x-ray and not by US were in the non-MRI-
examined hand. However, 3 x-ray erosions (all in PsA: 1 MCP
and 2 DIP joints) and 2 proliferations (both PsA: 2 DIP joints)
were located in the MRI-examined hand and were not regis-
tered by MRI (Figure 4). In 2 of the erosions, the anatomy was
not fully covered. US versus clinical examination agreements
and MRI versus clinical examination agreements were gener-
ally low (median 65%; range 38% to 100%) and were lowest
for MTP joints. Generally, agreements on the absence of find-
ings were more frequent than agreements on the presence of
findings.
Sensitivities and specificities of ultrasonography, x-ray, 
and clinical examination, with MRI as standard reference 
method
Sensitivities and specificities of US, x-ray, and clinical exami-
nation, with MRI as the standard reference method, are listed
in Table 5. The specificity of US and x-ray was high for all
pathologies. It is noted that US was more sensitive than x-ray
for detecting erosions, except in DIP joints. The sensitivity for
bone proliferations in DIP joints was high for both US and x-
ray. The sensitivity of US was highest for synovitis in MCP
joints and for tenosynovitis in PIP joints. The sensitivity of US
for detecting insertional changes and capsular/extracapsular
changes was high, except for insertional changes in the exten-
sor tendons. US consistently found more joints with synovitis
Table 1
Ultrasonography observations in psoriasis-associated arthritis and rheumatoid arthritis patients and healthy control persons
All Psoriasis-associated
arthritis
Rheumatoid arthritis Healthy control persons
Bone erosions
MCP joint 12% 13% 18% 3%
PIP joint 12% 14% 3% 13%
DIP joint 3% 4% 0% 0%
MTP joint 15% 15% 24% 6%
Bone proliferations
MCP joint 4% 6% 0% 0%
PIP joint 8% 12% 3% 0%
DIP joint 9% 13% 0% 5%
MTP joint 5% 5% 4% 6%
Synovitis
MCP joint 22% 19% 50% 3%
PIP joint 13% 13% 23% 3%
DIP joint 18% 22% 23% 3%
MTP joint 44% 43% 56% 34%
Tenosynovitis
MCP joint 7% 4% 23% 0%
PIP joint 18% 16% 40% 0%
DIP joint 6% 2% 20% 3%
Insertional changes
Extensor tendons 8% 12% 3% 3%
Flexor tendons 8% 7% 18% 0%
Capsular/extracapsular changes 9% 7% 25% 0%
Two hundred fingers (196 MCP, 199 PIP, and 200 DIP joints) and 250 MTP joints were examined. The distribution was as follows: psoriasis-
associated arthritis = 60 fingers (56 MCP, 59 PIP, and 60 DIP joints) and 150 MTP joints; rheumatoid arthritis = 20 fingers (20 MCP, 20 PIP, and 
20 DIP joints) and 50 MTP joints; and healthy control persons = 20 fingers (20 MCP, 20 PIP, and 20 DIP joints) and 50 MTP joints. DIP, distal 
interphalangeal; MCP, metacarpophalangeal; MTP, metatarsophalangeal; PIP, proximal interphalangeal.Arthritis Research & Therapy    Vol 9 No 6    Wiell et al.
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than the corresponding clinical examination (median sensitivity
0.50 versus 0.25).
Discussion
To our knowledge, this is the first study to examine small joints
in PsA using high-end US and comparing it with contrast-
enhanced MRI, x-ray, and clinical examination. A higher fre-
quency of DIP joint changes was found by US in the PsA
patients compared with RA patients. In particular, DIP joint
bone changes were found exclusively in PsA. Furthermore,
bone proliferations were more common and tenosynovitis was
less frequent in PsA than RA. For other pathologies, no dis-
ease-specific pattern was observed. US and MRI were more
sensitive to inflammatory and destructive changes than x-ray
and clinical examination, and US showed a high interobserver
agreement for bone changes and a lower interobserver agree-
ment for inflammatory changes (Figure 1). A high absolute
agreement (85% to 100%) for all destructive changes and a
more moderate absolute agreement (73% to 100%) for the
inflammatory pathologies were found between US and MRI.
In this study, US revealed synovitis more frequently in MCP
and PIP joints and bone erosions less frequently in PIP joints
in the RA group than in the PsA group, whereas Fournié and
colleagues [13] reported minimal differences in the amount of
erosion and synovitis in MCP and PIP joints of PsA and RA
patients. Fournié and colleagues [13], as in our study,
reported more tenosynovitis and a few osteoarthritic changes
(2 of 21 patients) in the RA group and only erosive DIP joint
changes in the PsA group. However, they exclusively found
extrasynovial changes in PsA patients, which we also detected
in 3 of the 5 RA patients (60% confirmed by MRI). Larger stud-
ies are required to provide final conclusions. Erosion-like
changes were detected by US in 5% of the CTRL joints (6 in
fingers and 3 in MTP joints) in our study (Figure 3). Szkudlarek
and colleagues found erosion-like changes in 1% of the MTP
joints [14] and 0% of the finger joints (MCP and PIP) [15],
whereas Døhn and colleagues [7] found erosion-like changes
in 38% (6 of 16) and Wakefield and colleagues [16] in 1% (1
of 100) of the examined MCP joints. Five of the 6 erosion-like
changes found in our study were located at the radial or ulnar
side of the 2nd and 3rd PIP joints and were all very small.
Schmidt and colleagues [17] did a circumferential scan of the
2nd PIP joints on 102 CTRLs and reported no erosive
changes. Døhn and colleagues [7] suggested that US may be
too sensitive, as MRI and computed tomography (CT) could
not confirm any of the erosion-like changes found by US. Sim-
ilarly, none of the US erosion-like changes in our study was
confirmed by MRI. The changes may be explained by a high
US sensitivity, but some may be physiologic bone notches
mistaken for erosions. Future studies with CT as the standard
reference method or longitudinal prognostic US studies can
provide stronger evidence on bone changes. Both synovitis,
especially in MTP joints [14,15], and tenosynovitis [17,18]
have been reported in CTRLs. Szkudlarek and colleagues
[14,15] reported synovitis in 8% of MTP joints compared with
34% in our study and 2.5% in MCP and PIP joints compared
with our 6%. Schmidt and colleagues [17] found signs of ten-
osynovitis, defined as a hypoechoic rim around 97% of the
2nd flexor tendons, whereas we detected this in only 3%.
However, in advance, we excluded minimal changes in our cal-
culations (Materials and methods). The fact that both US1 and
US2 found a high frequency of MTP joint synovitis indicates
that this observation was truly frequent in our control popula-
tion. Our high frequency of MTP synovitis in CTRLs may be
partly caused by asymptomatic osteoarthritis (OA), as one
third are found in the 1st MTP joint, which is often involved in
OA. Another contributing cause may be that the applied defi-
nitions of synovitis were too sensitive. However, the definitions
of MTP synovitis suggested by Koski and colleagues [19] and
Schmidt and colleagues [17] also included some of the cases
of MTP synovitis in CTRLs, which were found using our defini-
tions. Our results were obtained using US from dorsal, palmar/
plantar, and lateral projections. Further studies are needed to
determine whether examination from one or more planes can
be omitted without marked loss of sensitivity.
Figure 3
(a) Bone cortex defect (arrows) on ultrasonography in a 63-year-old healthy control person on the radial side of the 3rd proximal interphalangeal joint  in a longitudinal view (a) Bone cortex defect (arrows) on ultrasonography in a 63-year-old healthy control person on the radial side of the 3rd proximal interphalangeal joint 
in a longitudinal view. (b) The corresponding transverse view. (c) The coronal T1-weighted magnetic resonance image without contrast administra-
tion reveals no erosion-like changes in the same person at the corresponding site (arrows). IP, intermediate phalanx; PP, proximal phalanx.Available online http://arthritis-research.com/content/9/6/R119
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Table 2
Ultrasonography, MRI, and x-ray findings in the MRI-examined hand
Ultrasonography MRI X-ray
Bone erosions
MCP joint (total) 15% 16% 7%
PsA 18% 23% 12%
RA 15% 10% 0%
PIP joint (total) 15% 7% 5%
PsA 20% 8% 7%
RA 0% 10% 5%
DIP joint (total) 1% 3% 5%
PsA 2% 5% 8%
RA 0% 0% 0%
Bone proliferations
MCP joint (total) 4% 3% 0%
PsA 7% 5% 0%
RA 0% 0% 0%
PIP joint (total) 7% 6% 0%
PsA 12% 10% 0%
RA 0% 0% 0%
DIP joint (total) 7% 2% 4%
PsA 12% 3% 7%
RA 0% 0% 0%
Synovitis
MCP joint (total) 28% 27% NA
PsA 28% 35% NA
RA 55% 30% NA
PIP joint (total) 22% 20% NA
PsA 27% 23% NA
RA 30% 25% NA
DIP joint (total) 12% 5% NA
PsA 18% 7% NA
RA 5 % 5% NA
Tenosynovitis
MCP joint (total) 6% 13% NA
PsA 2% 12% NA
RA 25% 30% NA
PIP joint (total) 20% 7% NA
PsA 18% 5% NA
RA 45% 20% NAArthritis Research & Therapy    Vol 9 No 6    Wiell et al.
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In the present study, US and MRI were more sensitive than x-
ray and clinical examination in both PsA and RA, which is in
agreement with previous findings in RA [7-9,14-16,18,20,21].
It is of major interest whether bone changes, especially prolif-
erations, found in DIP joints in PsA can be distinguished from
bone changes found in OA. This has been addressed by Tan
and colleagues [22], who reported that DIP joints on MRI more
frequently showed enthesitis enhancement, entheseal erosion,
extracapsular changes, and diffuse bone edema in PsA than in
OA. We did not examine an OA group, but bone proliferations
and insertional changes found in DIP joints of two 63-year-old
CTRLs were probably caused by asymptomatic OA. Further-
more, all bone proliferations found in CTRL MTP joints were
located on the medial side of the 1st MTP joint, which is a fre-
quent location of OA. The same was the case in the RA group,
suggesting concomitant OA as the cause, whereas only three
of the seven proliferations found in the PsA group were
located there.
US is often criticized for being operator-dependent. Our anal-
ysis of interobserver agreement showed a higher agreement
for both inflammatory and destructive changes (median 96%)
than seen in a European League Against Rheumatism
(EULAR) interobserver study [23] in which 14 experienced
ultrasonographers examined fingers and wrist (median 73%).
The pattern of higher kappa values for bone changes than for
inflammatory changes found in our study is concordant with
other studies [10,23].
US and MRI showed high concordance (85% to 100%) for all
destructive changes and a more moderate concordance (73%
to 100%) for the inflammatory pathologies. This lower agree-
ment for inflammatory changes has also been reported by oth-
ers [8,14,15]. Szkudlarek and colleagues [15] found an overall
agreement for synovitis of 76% (versus 82% in our study). In
the EULAR study, the overall agreement between US and MRI
for fingers and wrist was 73% [23]. The agreement between
US and MRI for tenosynovitis was low. Contributing causes
may be that US can detect small tendon sheath effusions
(especially at the PIP joints) that may not show post-contrast
enhancement on MRI [24] and that it can be difficult to distin-
guish synovitis from tenosynovitis by US. The latter very prob-
ably also contributes to the rather low US interobserver
reproducibility for synovitis and tenosynovitis.
X-ray is the routine imaging modality for following the destruc-
tive changes in clinical practice in patients with arthritis. Many
RA studies have shown higher sensitivity of US than x-ray for
detecting erosions in RA patients [15,16,21,24], without loss
of specificity [15]. Our US sensitivities for erosions, when MRI
was considered the standard reference method, showed the
same tendency, although not as clearly as in RA [15]. A con-
tributing cause to the lower sensitivity in our study could be
that we examined smaller anatomical structures (DIP joints
and entheses included). Also, on MRI, detecting such
changes may be difficult. This explains why x-ray found some
bone changes that were not revealed by US and MRI and why
US detected some pathologies (small bone proliferations, DIP
synovitis, and insertional changes) more frequently than MRI.
In particular, the distinction of capsular enhancement from
extracapsular enhancement was difficult by MRI. However,
this was met by scoring the two together. The present results
were obtained with a 0.6-tesla magnet, and MRI data that are
even more detailed may be obtained with higher field
DIP joint (total) 6% 6% NA
PsA 2% 3% NA
RA 25% 20% NA
Insertional changes
Extensor tendons (total) 6% 4% NA
PsA 8% 7% NA
RA 5% 0% NA
Flexor tendons (total) 9% 4% NA
PsA 3% 0% NA
RA 35% 20% NA
Capsular/extracapsular changes (total) 18% 7% NA
PsA 22% 7% NA
RA 25% 15% NA
One hundred fingers (100 MCP, 100, PIP, and 100 DIP joints) ('total') were examined. The distribution was as follows: psoriasis-associated 
arthritis (PsA) = 60; rheumatoid arthritis (RA) = 20; and healthy control persons (not shown) = 20. The imaging modalities were ultrasonography, 
magnetic resonance imaging (MRI), and projection radiography (x-ray). DIP, distal interphalangeal; MCP, metacarpophalangeal; NA, not 
applicable; PIP, proximal interphalangeal.
Table 2 (Continued)
Ultrasonography, MRI, and x-ray findings in the MRI-examined handAvailable online http://arthritis-research.com/content/9/6/R119
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Table 3
Agreements between US, MRI, and x-ray for bone changes
US1 versus US2 US versus MRI US versus x-ray MRI versus x-ray
Bone erosions
MCP joint (total) 95%; κ = 0.795 87%; κ = 0.504 89%; κ = 0.268 89%; κ = 0.470
PsA 95%; κ = 0.830 85%; κ = 0.547 88%; κ = 0.358 85%; κ = 0.492
RA 88%; κ = 0.600 85%; κ = 0.318 83%; κ = NA 90%; κ = NA
CTRL 100%; κ = NA 95%; κ = NA 95%; κ = NA 100%; κ = NA
PIP joint (total) 86%; κ = 0.522 86%; κ = 0.296 87%; κ = 0.361 92%; κ = 0.292
PsA 83%; κ = 0.526 85%; κ = 0.400 85%; κ = 0.411 88%; κ = 0.160
RA 100%; κ = NA 90%; κ = NA 93%; κ = 0.375 95%; κ = 0.643
CTRL 88%; κ = NA 85%; κ = NA 88%; κ = NA 100%; κ = NA
DIP joint (total) 100%; κ = 1.000 96%; κ = -0.015 96%; κ = 0.506 96%; κ = 0.481
PsA 100%; κ = 1.000 93%; κ = -0.026 93%; κ = 0.527 93%; κ = 0.467
RA 100%; κ = NA 100%; κ = NA 100%; κ = NA 100%; κ = NA
CTRL 100%; κ = NA 100%; κ = NA 100%; κ = NA 100%; κ = NA
MTP joint (total) 90%; κ = 0.702 - 89%; κ = 0.259 -
PsA 90%; κ = 0.799 - 89%; κ = 0.378 -
RA 100%; κ = 1.000 - 78%; κ = -0.084 -
CTRL 90%; κ = 0.783 - 100%; κ = NA -
Bone proliferations
MCP joint (total) 97%; κ = 0.783 93%; κ = -0.036 96%; κ = NA 97%; κ = NA
PsA 95%; κ = 0.776 88%; κ = -0.061 94%; κ = NA 95%; κ = NA
RA 100%; κ = NA 100%; κ = NA 100%; κ = NA 100%; κ = NA
CTRL 100%; κ = NA 100%; κ = NA 100%; κ = NA 100%; κ = NA
PIP joint (total) 92%; κ = 0.665 93%; κ = 0.424 93%; κ = 0.117 94%; κ = NA
PsA 89%; κ = 0.648 88%; κ = 0.397 89%; κ = 0.120 90%; κ = NA
RA 100%; κ = NA 100%; κ = NA 98%; κ = NA 100%; κ = NA
CTRL 100%; κ = NA 100%; κ = NA 100%; κ = NA 100%; κ = NA
DIP joint (total) 95%; κ = 0.851 95%; κ = 0.427 94%; κ = 0.472 98%; κ = 0.658
PsA 94%; κ = 0.838 92%; κ = 0.414 91%; κ = 0.476 97%; κ = 0.651
RA 100%; κ = NA 100%; κ = NA 100%; κ = NA 100%; κ = NA
CTRL 100%; κ = NA 100%; κ = NA 95%; κ = NA 100%; κ = NA
MTP joint (total) 93%; κ = 0.515 - 99%; κ = NA -
PsA 92%; κ = 0.250 - 98%; κ = NA -
RA 100%; κ = 1.000 - 100%; κ = NA -
CTRL 100%; κ = NA - 100%; κ = NA -
Values are absolute agreement presented as a percentage. The imaging modalities were ultrasonography (US), magnetic resonance imaging 
(MRI), and projection radiography (x-ray). The interobserver substudy was performed by ultrasonographer 1 (Charlotte Wiell = US1) and 
ultrasonographer 2 (Marcin Szkudlarek = US2). A hyphen (-) indicates that the measurement was not performed. κ, kappa value; CTRL, healthy 
control person; DIP, distal interphalangeal; MCP, metacarpophalangeal; MTP, metatarsophalangeal; NA, not applicable; PIP, proximal 
interphalangeal; PsA, psoriasis-associated arthritis; RA, rheumatoid arthritis.Arthritis Research & Therapy    Vol 9 No 6    Wiell et al.
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Table 4
Agreements between US, MRI, and clinical examination for inflammatory changes
US1 versus US2 US versus MRI USa versus clinical
examinationb
MRIc versus clinical
examinationb
Synovitis
MCP joint (total) 88%; κ = 0.305 83%; κ = 0.574 62%; κ = -0.033 63%; κ = 0.047
PsA 84%; κ = 0.280 80%; κ = 0.540 62%; κ = 0.047 64%; κ = 0.131
RA 100%; κ = NA 75%; κ = 0.519 63%; κ = -0.007 60%; κ = 0.091
CTRL 100%; κ = NA 100%; κ = NA 63%; κ = NA 100%; κ = NA
PIP joint (total) 78%; κ = 0.361 78%; κ = 0.337 66%; κ = NA 66%; κ = 0.012
PsA 84%; κ = 0.367 73%; κ = 0.290 64%; κ = -0.053 68%; κ = 0.149
RA 50%; κ = 0.059 75%; κ = 0.375 63%; κ = 0.162 50%; κ = -0.190
CTRL 100%; κ = NA 95%; κ = NA 73%; κ = NA 95%; κ = NA
DIP joint (total) 83%; κ = 0.129 87%; κ = 0.177 74%; κ = -0.020 79%; κ = -0.082
PsA 84%; κ = 0.120 78%; κ = 0.039 72%; κ = 0.041 68%; κ = -0.098
RA 100%; κ = NA 100%; κ = 1.000 83%; κ = -0.077 90%; κ = -0.053
CTRL 100%; κ = NA 100%; κ = NA 73%; κ = NA 100%; κ = NA
MTP joint (total) 91%; κ = 0.825 - 51%; κ = -0.063 -
PsA 90%; κ = 0.799 - 55%; κ = -0.038 -
RA 100%; κ = 1.000 - 52%; κ = -0.034 -
CTRL 90%; κ = 0.783 - 38%; κ = NA -
Tenosynovitis
MCP joint (total) 93%; κ = -0.034 91%; κ = 0.484 - -
PsA 91%; κ = -0.048 90%; κ = 0.227 - -
RA 100%; κ = NA 85%; κ = 0.625 - -
CTRL 100%; κ = NA 100%; κ = NA - -
PIP joint (total) 87%; κ = -0.029 96%; κ = 0.645 - -
PsA 89%; κ = -0.035 87%; κ = 0.380 - -
RA 63%; κ = NA 75%; κ = 0.468 - -
CTRL 100%; κ = NA 100%; κ = NA - -
DIP joint (total) 97%; κ = NA 96%; κ = 0.645 - -
PsA 98%; κ = NA 98%; κ = 0.659 - -
RA 88%; κ = NA 85%; κ = 0.571 - -
CTRL 100%; κ = NA 100%; κ = NA - -
Insertional changes
Extensor tendons (total) 88%; κ = NA 94%; κ = 0.370 - -
PsA 83%; κ = NA 92%; κ = 0.400 - -
RA 100%; κ = NA 95%; κ = NA - -
CTRL 100%; κ = NA 100%; κ = NA - -
Flexor tendons (total) 98%; κ = NA 95%; κ = 0.593 - -
PsA 98%; κ = NA 97%; κ = NA - -
RA 100%; κ = NA 85%; κ = 0.634 - -
CTRL 100%; κ = NA 100%; κ = NA - -
Capsular/extra-capsular changes
Total 86%; κ = NA 87%; κ = 0.511 - -
PsA 83%; κ = NA 88%; κ = 0.410 - -
RA 88%; κ = NA 90%; κ = 0.692 - -
CTRL 100%; κ = NA 100%; κ = NA - -
aUltrasonography (US) synovitis (synovial hypertrophy and/or effusion, and/or power Doppler signal); bclinically tender and swollen joints; 
cmagnetic resonance imaging (MRI) synovitis. Values are absolute agreement presented as a percentage. The imaging modalities were US, MRI, 
and clinical examination. The interobserver substudy was performed by ultrasonographer 1 (Charlotte Wiell = US1) and ultrasonographer 2 
(Marcin Szkudlarek = US2). A hyphen (-) indicates that the measurement was not performed. κ, kappa value; CTRL, healthy control person; DIP, 
distal interphalangeal; MCP, metacarpophalangeal; MTP, metatarsophalangeal; NA, not applicable; PIP, proximal interphalangeal; PsA, psoriasis-
associated arthritis; RA, rheumatoid arthritis.Available online http://arthritis-research.com/content/9/6/R119
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Figure 4
Projection radiography (x-ray) (a) and T1-weighted coronal (b) and axial (c) magnetic resonance imaging (MRI) and ultrasonography (US) in longitu- dinal dorsal (d) and palmar (e) views of the 3rd distal interphalangeal joint of a patient with psoriasis-associated arthritis Projection radiography (x-ray) (a) and T1-weighted coronal (b) and axial (c) magnetic resonance imaging (MRI) and ultrasonography (US) in longitu-
dinal dorsal (d) and palmar (e) views of the 3rd distal interphalangeal joint of a patient with psoriasis-associated arthritis. An erosion was scored on 
x-ray (a) but not on either MRI (b,c) or US (d,e), even though small irregularities were seen. DP, distal phalanx; IP, intermediate phalanx.
Table 5
Sensitivity and specificity of US, x-ray, and clinical examination, with MRI as the standard reference method
US sensitivity US specificity X-ray sensitivity X-ray specificity Clinical
examination
sensitivity
Clinical
examination
specificity
Bone erosions
MCP joint 0.56 0.93 0.38 0.99 NA NA
PIP joint 0.57 0.88 0.40 0.95 NA NA
DIP joint 0.00 0.99 0.67 0.97 NA NA
Bone proliferations
MCP joint 0.00 0.97 0.00 0.96 NA NA
PIP joint 0.50 0.96 0.00 0.96 NA NA
DIP joint 1.00 0.95 1.00 0.98 NA NA
Synovitis
MCP joint 0.70 0.88 NA NA 0.31 0.74
PIP joint 0.50 0.88 NA NA 0.25 0.76
DIP joint 0.40 0.87 NA NA 0.00 0.83
Tenosynovitis
MCP joint 0.38 0.99 NA NA NA NA
PIP joint 1.00 0.86 NA NA NA NA
DIP joint 0.67 0.98 NA NA NA NA
Insertional changes
Extensor tendons 0.50 0.96 NA NA NA NA
Flexor tendons 1.00 0.95 NA NA NA NA
Capsular/extracapsular changes 1.00 0.88 NA NA NA NA
The imaging modalities were ultrasonography (US), magnetic resonance imaging (MRI), projection radiography (x-ray), and clinical examination. 
DIP, distal interphalangeal; MCP, metacarpophalangeal; NA, not applicable; PIP, proximal interphalangeal.Arthritis Research & Therapy    Vol 9 No 6    Wiell et al.
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strengths (1.5-tesla or 3.0-tesla MRI). As findings by MRI are
minimally validated, it can be debated whether MRI is the ideal
standard reference. CT, though not better validated than MRI,
is a potentially superior option as a reference method for bone
changes. Clinical examination showed lower sensitivity
(median 0.25) than US (median 0.50) for the detection of
inflammatory changes (synovitis). This is in agreement with
several previous reports [8,14,15,18].
Conclusion
The present study has demonstrated that both US and MRI are
more sensitive for visualization of inflammatory and destructive
changes in fingers and toes of patients with PsA. The US inter-
observer agreement was high for bone changes but was lower
for inflammatory changes, whereas the intermodality (US ver-
sus MRI) agreement was moderate to high. In comparison with
RA patients, PsA patients showed more DIP joint changes.
Furthermore, bone proliferations were more common and ten-
osynovitis was less frequent in PsA than RA. Even though fur-
ther studies are needed (for example, on definitions of
pathologies, standardization of methods, sensitivity to change,
and prognostic value), it seems evident that both US and MRI
have major potential for improved examination of joints, ten-
dons, and entheses in fingers and toes of patients with PsA.
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